Diaceutics PLC (DXRX.L)

GBp 121.5

(-0.41%)

EBITDA Summary of Diaceutics PLC

Diaceutics PLC's latest annual EBITDA in 2023 was 2.35 Million GBP , down -38.45% from previous year.
Diaceutics PLC's latest quarterly EBITDA in 2024 Q2 was -961 Thousand GBP , down 0.0% from previous quarter.
Diaceutics PLC reported an annual EBITDA of 3.6 Million GBP in 2022, up 58.1% from previous year.
Diaceutics PLC reported an annual EBITDA of 2.11 Million GBP in 2021, up 961.31% from previous year.
Diaceutics PLC reported a quarterly EBITDA of N/A for 2023 FY, down -38.45% from previous quarter.
Diaceutics PLC reported a quarterly EBITDA of 1.22 Million GBP for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Diaceutics PLC (2023 - 2015)

Historical Annual EBITDA of Diaceutics PLC (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	2.35 Million GBP	-38.45%
2022	3.6 Million GBP	58.1%
2021	2.11 Million GBP	961.31%
2020	178 Thousand GBP	-91.73%
2019	847.58 Thousand GBP	80.8%
2018	1.29 Million GBP	43.4%
2017	922.17 Thousand GBP	-11.62%
2016	584.17 Thousand GBP	1854.55%
2015	-59.83 Thousand GBP	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	-961 Thousand GBP	0.0%
2023 FY	- GBP	-38.45%
2023 Q4	1.22 Million GBP	0.0%
2023 Q2	-240 Thousand GBP	0.0%
2022 Q4	3.29 Million GBP	0.0%
2022 Q2	177 Thousand GBP	0.0%
2022 FY	- GBP	58.1%
2021 FY	- GBP	961.31%
2021 Q4	2.02 Million GBP	0.0%
2021 Q2	131 Thousand GBP	0.0%
2020 Q2	158.19 Thousand GBP	0.0%
2020 FY	- GBP	-91.73%
2020 Q4	98.81 Thousand GBP	0.0%
2019 Q4	2.54 Million GBP	0.0%
2019 FY	- GBP	80.8%
2019 Q2	-335.32 Thousand GBP	0.0%
2018 FY	- GBP	43.4%
2018 Q4	2.52 Million GBP	0.0%
2018 Q2	-1 Million GBP	0.0%
2017 Q1	230.54 Thousand GBP	0.0%
2017 FY	- GBP	-11.62%
2017 Q2	230.54 Thousand GBP	0.0%
2017 Q4	324.13 Thousand GBP	0.0%
2016 Q2	260.12 Thousand GBP	0.0%
2016 FY	- GBP	1854.55%
2016 Q1	260.12 Thousand GBP	0.0%
2016 Q4	230.54 Thousand GBP	0.0%
2015 FY	- GBP	0.0%
2015 Q4	260.12 Thousand GBP	0.0%

Peer EBITDA Comparison of Diaceutics PLC

Name	EBITDA	EBITDA Difference